Research & achievements研究・業績
Research paper研究論文-和文-
2018年度英文
-
英文 原著他 (PubMed順)2018年度
-
Advanced parametric imaging for evaluation of Crohn’s disease using dual-energy computed tomography enterography.
Radiol Case Rep 13,P.709-712 / 2022
-
-
英文(PubMed順) 2018年度
-
Impact of retroflexion in the right colon after repeated forward-view examinations.
JGH open 2,P.282-287 / 2018
-
Functional Analysis of Human Hepatocytes Isolated From Chimeric Mouse Liver
Transplant Proc 50,P.3858-3862 / 2018
-
Circulating let-7 Levels in Serum Correlate With the Severity of Hepatic Fibrosis in Chronic Hepatitis C.
Open Forum Infect Dis 5,P.ofy268 / 2018
-
Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti-viral therapy in patients with chronic hepatitis B
Aliment Pharmacol Ther 48,P.1128-1137 / 2018
-
Increased EZH2 expression during the adenoma-carcinoma sequence in colorectal cancer.
Oncol Lett 16,P.5275-5281 / 2018
-
Type I interferon signaling prevents hepatitis B virus-specific T cell responses by reducing antigen expression
J Virol 92,P.e01099 / 2018
-
Intrahepatic Cross-Presentation and Hepatocellular Antigen Presentation Play Distinct Roles in the Induction of Hepatitis B Virus-Specific CD8 + T Cell Responses
J Virol 92,P.e01099 / 2018
-
Screening of microRNAs for a repressor of hepatitis B virus replication
Oncotarget 9,P.29857-29868 / 2018
-
Sofosbuvir–velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals
Hepatol Int 12,P.356-367 / 2018
-
Dysregulation of miRNA in chronic hepatitis B is associated with hepatocellular carcinoma risk after nucleos(t)ide analogue treatment.
Cancer Lett 434,P.91-100 / 2018
-
Clinical evaluation of a novel and highly sensitive immunoassay for anti-hepatitis B core antigen using a fully automated immunochemical analyzer
Hepatol Res 48,P.1081-1091 / 2018
-
Suppression of hepatitis B surface antigen production by combination therapy with nucleotide analogues and interferon in children with genotype C hepatitis B virus infection
Hepatol Res 48,P.1172-1177 / 2018
-
De Novo Macrocyclic Peptide Inhibitors of Hepatitis B Virus Cellular Entry
Cell Chem Biol 25,P.906-915. e7 / 2018
-
Differentiation Therapy by Epigenetic Reconditioning Exerts Antitumor Effects on Liver Cancer Cells
Mol Ther 26,P.1840-1854 / 2018
-
Real-world virological efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C virus genotype 1 infection in Japan
J Gastroenterol 53,P.1276-1284 / 2018
-
Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein level as a diagnostic marker of hepatitis B virus-related hepatocellular carcinoma
Hepatol Res 48,P.872-881 / 2018
-
Gut dysbiosis associated with hepatitis C virus infection
Clin Infect Dis 67,P.869-877 / 2018
-
Efficacy and safety of ledipasvir/sofosbuvir for genotype 1b chronic hepatitis C patients with moderate renal impairment
Hepatol Int 12,P.133-142 / 2018
-
Modeling of the Weight Status and Risk of Nonalcoholic Fatty Liver Disease in Elderly Individuals: The Potential Impact of the Disulfide Bond-Forming Oxidoreductase A-Like Protein (DsbA-L) Polymorphism on the Weight Status.
CPT Pharmacometrics Syst Pharmacol 7,P.384-393 / 2018
-
Efficacy and safety of ombitasvir/paritaprevir/ritonavir combination therapy for genotype 1b chronic hepatitis C patients complicated with chronic kidney disease
Hepatol Res 48,P.549-555 / 2018
-
Vonoprazan is Superior to Rabeprazole for Healing Endoscopic Submucosal Dissection: Induced Ulcers
Hepatol Res 97,P.170-176 / 2018
-
High levels of serum Mac-2-binding protein glycosylation isomer (M2BPGi) predict the development of hepatocellular carcinoma in hepatitis B patients treated with nucleot(s)ide analogues
J Gastroenterol 53,P.883-889 / 2018
-
Antiviral therapy for hepatitis B virus during second pregnancies
J Obstet Gynaecol Res 44,P.566-569 / 2018
-
Late relapse after a sustained virologic response at 24 weeks after treatment with daclatasvir and asunaprevir combination therapy for chronic hepatitis c virus genotype 1b infection with liver cirrhosis
Intern Med 57,P.951-956 / 2018
-
Changes in serum lipid profiles caused by three regimens of interferon-free direct-acting antivirals for patients infected with hepatitis C virus
Hepatol Res 48,P.E203-E212 / 2018
-
Predictive role of serum HBsAg and HBcrAg kinetics in patients with HBeAg-negative chronic hepatitis B receiving pegylated interferon–based therapy
Clin Microbiol Infect 24,P.306. e7-306. e13 / 2018
-
Combination of PNPLA3 and TLL1 polymorphism can predict advanced fibrosis in Japanese patients with nonalcoholic fatty liver disease
J Gastroenterol 53,P.438-448 / 2018
-
Combinational use of hepatitis B viral antigens predicts responses to nucleos(t)ide analogue/peg-interferon sequential therapy.
J Gastroenterol 53,P.247-257 / 2018
-
Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan
J Gastroenterol 53,P.119-128 / 2018
-
Effect of hepatitis B virus subgenotype on antiviral response in nucleoside-treated hepatitis B envelope antigen-positive patients
Hepatol Res 48,P.134-143 / 2018
-